Genetic Testing Labs: Seize the Moment!

A genomics revolution has been underway for nearly a decade, and clinical laboratories are the catalyst. An exponentially growing body of clinical evidence shows doctors can diagnose and treat some of
the most deadly and persistent forms of cancer by looking to the genome. And as the new world of pathway-based therapeutics intersects with faster and cheaper DNA/RNA sequencing technologies, physicians, researchers, and patients are turning toward molecular pathology laboratories to lead the way.

You want to expand your use of the new diagnostic tools for your patient population. And to do so, you are developing clinical NGS-based assays and planning to bring them online as quickly and cost-effective as possible. 

Download our new whitepaper in collaboration with SeraCare to learn more.